NCT05093621View on ClinicalTrials.gov

Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Heart Failure
Interventions
DRUG

Furosemide

Standard of care diuretic

DRUG

Torsemide

Standard of care diuretic

Trial Locations (1)

06510

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT05093621 - Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure | Biotech Hunter | Biotech Hunter